Zalicus Inc. to Present at the 2013 Biotechnology Industry Organization (BIO) CEO & Investor Conference
Published: Feb 05, 2013
Zalicus Inc. (NASDAQ: ZLCS), a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain, today announced that Zalicus management will present at the 2013 BIO CEO & Investor Conference at 9:00 p.m. ET on Tuesday, February 12, 2013 at the Waldorf Astoria in New York. Interested parties may access a live webcast of the presentation by visiting the Zalicus website at www.zalicus.com. The webcast will be archived on the Zalicus website following the event.